Time-dependent increase in Nogo-A expression after focal cerebral ischemia in marmoset monkeys

Neuroscience Letters

Volumn 408, Issue 2, 2006, Pages 89-93

  Eslamboli, Andisheh ^a   Grundy, Robert I ^a   Irving, Elaine A ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Marmoset; Nogo A; Oligodendrocyte; Plasticity; Stroke

Indexed keywords

PROTEIN NOGO A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN DAMAGE; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN REGION; CELL COUNT; CONTROLLED STUDY; CORPUS CALLOSUM; GRAY MATTER; MIDDLE CEREBRAL ARTERY OCCLUSION; MONKEY; NERVE CELL PLASTICITY; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; STAINING; STROKE; WHITE MATTER;

ANIMALS; BRAIN; BRAIN ISCHEMIA; CALLITHRIX; GROWTH INHIBITORS; INFARCTION, MIDDLE CEREBRAL ARTERY; MYELIN PROTEINS; TIME FACTORS;

EID: 33749402928     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2006.08.056     Document Type: Article

References (25)

1. Bandtlow C.E., Dlaska M., Pirker S., Czech T., Baumgartner C., and Sperk G. Increased expression of Nogo-A in hippocampal neurons of patients with temporal lobe epilepsy. Eur. J. Neurosci. 20 (2004) 195-206
2. Butt A.M., and Ransom B.R. Visualization of oligodendrocytes and astrocytes in the intact rat optic nerve by intracellular injection of lucifer yellow and horseradish peroxidase. Glia 2 (1989) 470-475
3. Carmichael S.T., Wei L., Rovainen C.M., and Woolsey T.A. New patterns of intracortical projections after focal cortical stroke. Neurobiol. Dis. 8 (2001) 910-922
4. Chen M.S., Huber A.B., van der Haar M.E., Frank M., Schnell L., Spillmann A.A., Christ F., and Schwab M.E. Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature 403 (2000) 434-439
5. Dancause N., Barbay S., Frost S.B., Plautz E.J., Chen D., Zoubina E.V., Stowe A.M., and Nudo R.J. Extensive cortical rewiring after brain injury. J. Neurosci. 25 (2005) 10167-10179
6. Dewar D., Yam P., and McCulloch J. Drug development for stroke: importance of protecting cerebral white matter. Eur. J. Pharmacol. 375 (1999) 41-50
7. Dupuis L., Gonzalez de Aguilar J.L., Di Scala F., Rene F., De Tapia M., Pradat P.F., Lacomblez L., Seihlan D., Prinjha R., Walsh F.S., Meininger V., and Loeffler J.P. Nogo provides a molecular marker for diagnosis of amyotrophic lateral sclerosis. Neurobiol. Dis. 10 (2002) 358-365
8. Huber A.B., Weinmann O., Brosamle C., Oertle T., and Schwab M.E. Patterns of Nogo mRNA and protein expression in the developing and adult rat and after CNS lesions. J. Neurosci. 22 (2002) 3553-3567
9. Hunt D., Coffin R.S., Prinjha R.K., Campbell G., and Anderson P.N. Nogo-A expression in the intact and injured nervous system. Mol. Cell Neurosci. 24 (2003) 1083-1102
10. Irving E.A., Bentley D.L., and Parsons A.A. Assessment of white matter injury following prolonged focal cerebral ischaemia in the rat. Acta Neuropathol. (Berl) 102 (2001) 627-635
11. Irving E.A., Yatsushiro K., McCulloch J., and Dewar D. Rapid alteration of tau in oligodendrocytes after focal ischemic injury in the rat: involvement of free radicals. J. Cereb. Blood Flow Metab. 17 (1997) 612-622
12. Josephson A., Widenfalk J., Widmer H.W., Olson L., and Spenger C. NOGO mRNA expression in adult and fetal human and rat nervous tissue and in weight drop injury. Exp. Neurol. 169 (2001) 319-328
13. Lee J.K., Kim J.E., Sivula M., and Strittmatter S.M. Nogo receptor antagonism promotes stroke recovery by enhancing axonal plasticity. J. Neurosci. 24 (2004) 6209-6217
14. Marshall J.W., Duffin K.J., Green A.R., and Ridley R.M. NXY-059, a free radical-trapping agent, substantially lessens the functional disability resulting from cerebral ischemia in a primate species. Stroke 32 (2001) 190-198
15. Marshall J.W., and Ridley R.M. Assessment of functional impairment following permanent middle cerebral artery occlusion in a non-human primate species. Neurodegeneration 5 (1996) 275-286
16. Marshall J.W., and Ridley R.M. Assessment of cognitive and motor deficits in a marmoset model of stroke. ILAR J. 44 (2003) 153-160
17. McKerracher L., David S., Jackson D.L., Kottis V., Dunn R.J., and Braun P.E. Identification of myelin-associated glycoprotein as a major myelin-derived inhibitor of neurite growth. Neuron 13 (1994) 805-811
18. Mingorance A., Fontana X., Soriano E., and Del Rio J.A. Overexpression of myelin-associated glycoprotein after axotomy of the perforant pathway. Mol. Cell Neurosci. 29 (2005) 471-483
19. Ness J.K., Valentino M., McIver S.R., and Goldberg M.P. Identification of oligodendrocytes in experimental disease models. Glia 50 (2005) 321-328
20. Papadopoulos C.M., Tsai S.Y., Alsbiei T., O'Brien T.E., Schwab M.E., and Kartje G.L. Functional recovery and neuroanatomical plasticity following middle cerebral artery occlusion and IN-1 antibody treatment in the adult rat. Ann. Neurol. 51 (2002) 433-441
21. Seymour A.B., Andrews E.M., Tsai S.Y., Markus T.M., Bollnow M.R., Brenneman M.M., O'Brien T.E., Castro A.J., Schwab M.E., and Kartje G.L. Delayed treatment with monoclonal antibody IN-1 1 week after stroke results in recovery of function and corticorubral plasticity in adult rats. J. Cereb. Blood Flow Metab. 25 (2005) 1366-1375
22. Stephan H., Baron G., and Schwerdtfeger W.K. The Brain of the Common Marmoset (Callithrix jacchus) A stereotaxic atlas (1980), Springer-Verlag, Berlin
23. Wang K.C., Koprivica V., Kim J.A., Sivasankaran R., Guo Y., Neve R.L., and He Z. Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth. Nature 417 (2002) 941-944
24. Wiessner C., Bareyre F.M., Allegrini P.R., Mir A.K., Frentzel S., Zurini M., Schnell L., Oertle T., and Schwab M.E. Anti-Nogo-A antibody infusion 24 h after experimental stroke improved behavioral outcome and corticospinal plasticity in normotensive and spontaneously hypertensive rats. J. Cereb. Blood Flow Metab. 23 (2003) 154-165
25. Zhou C., Li Y., Nanda A., and Zhang J.H. HBO suppresses Nogo-A, Ng-R, or RhoA expression in the cerebral cortex after global ischaemia. Biochem. Biophys. Res. Commun. 309 (2003) 368-376